NOVEL FORMULATION OF CT-P13 (Infliximab biosimilar) FOR SUBCUTANEOUS ADMINISTRATION: 30 WEEK RESULTS FROM A PART 2 of PHASE I/III RANDOMISED CONTROLLED TRIAL IN PATIENTS WITH RHEUMATOID ARTHRITIS.

  • 유대현
제목
NOVEL FORMULATION OF CT-P13 (Infliximab biosimilar) FOR SUBCUTANEOUS ADMINISTRATION: 30 WEEK RESULTS FROM A PART 2 of PHASE I/III RANDOMISED CONTROLLED TRIAL IN PATIENTS WITH RHEUMATOID ARTHRITIS.
저자
유대현
발행일
2019-06-15
학회명
EULAR 2018
개최지
Madrid, Spain